Search Results - "Souza, Zenaide Silva"

Emerging biomarkers in metastatic urothelial carcinoma: tumour mutational burden, PD-L1 expression and APOBEC polypeptide-like signature in a patient with complete response to anti-programmed cell death protein-1 inhibitor by Queiroz, Marcello Moro, de Souza, Zenaide Silva, Gongora, Aline Bobato Lara, de Galiza Barbosa, Felipe, Buchpiguel, Carlos Alberto, de Castro, Marilia Germanos, de Macedo, Mariana Petaccia, Coelho, Rafael Ferreira, Sokol, Ethan Samuel, Camargo, Anamaria Aranha, Bastos, Diogo Assed

“…Immunotherapy has recently been incorporated into the treatment guidelines for metastatic urothelial carcinoma. Nevertheless, the role of prognostic and…”
Get full text

Primary Peritoneal Carcinosarcoma in a Breast Cancer Patient Harboring a Germline BRCA2 Pathogenic Variant: Case Report by Mendes Gomes, Luciana Beatriz, Lazari Sandoval, Renata, Bragança Xavier, Camila, Strava Correa, Tatiana, Koga Matuda, Raquel Midori, Silva de Souza, Zenaide, Cernaglia Aureliano de Lima, Luiz Guilherme, Petaccia de Macedo, Mariana, Marino Carvalho, Filomena, Assad Suzuki, Daniele

“…Abstract Malignant mixed müllerian tumor (MMMT) is a rare neoplasm, consisting of carcinomatous (epithelial) and sarcomatous (mesenchymal) components that most…”
Get full text

Survival and Response Outcomes for Gastrointestinal Neuroendocrine Tumor (GEP-NETs) Patients Treated with Lutetium—177-DOTATATE in a Brazilian Reference Center: A Six-Year Follow-Up Experience by de Souza, Zenaide Silva, Xavier, Camila Bragança, Gomes, Luciana Beatriz Mendes, de Medeiros, Maria Fernanda Barbosa, de Sousa, Micelange Carvalho, Pereira, Allan Andresson Lima, Marin, José Flávio Gomes, Buchpiguel, Carlos Alberto, Costa, Frederico Perego

“…Background: PRRT can be an option for all-grade GEP-NETs, but selecting patients is challenging. In this scenario, clinical-pathological and radiological…”
Get full text

COVID-19 in a patient with advanced Merkel cell carcinoma receiving immunotherapy by da Costa, Cesar Martins, de Souza, Zenaide Silva, Real Salgues, Alessandra Corte, Harada, Guilherme, Marino Rodrigues Ayres, Pedro Paulo, Vieira Nunes, Daniela Bulhões, Katz, Artur, Munhoz, Rodrigo Ramella

“…Little is known about the 2019 novel coronavirus disease (COVID-19) course and outcomes in patients receiving immunotherapy. Here we describe a metastatic…”
Get full text

Survival outcomes for patients (pts) with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with lutetium-177-dotatate (Lu-177) in a Brazilian reference center: A six-year follow-up experience by Souza, Zenaide Silva, Xavier, Camila Bragança, Mendes Gomes Siqueira, Luciana Beatriz, Barbosa de Medeiros, Maria Fernanda, de Souza, Micelange Carvalho, Begnami, Maria Dirlei de Souza, Pereira, Allan Andresson Lima, Marin, José Flávio Gomes, Buchpiguel, Carlos Alberto, Costa, Frederico

“…642 Background: GEP-NETs are the most common NETs primary site. Lu-177 is the standard treatment for patients with grade 1 (G1) or grade 2 (G2) midgut NETs who…”
Get full text

Prediction of pathologic complete response to chemoimmunotherapy in triple-negative breast cancer using tumor-infiltrating lymphocytes: Exploiting cutoff values by BARROSO-SOUSA, ROMUALDO, Sousa, Isadora Martins de, Marin Comini, Ana Carolina, Celeste Tavares, Monique, Madasi Pinheiro, Fernanda, Bines, Jose, Dal Ponte Ferreira, Rafael, Rosa, Daniela Dornelles, Santos, Candice Lima, Souza, Zenaide Silva, Suzuki, Daniele Assad, de Araujo, Julio Antônio Pereira, Gagliato, Debora De Melo, Dos Anjos, Carlos Henrique, Zucchetti, Bruna M, Ferrari, Anezka Carvalho Rubin de Celis, Lopes De Brito, Mayana, Monteiro, Maria Marcela F., Testa, Laura, Bonadio, Renata Colombo

“…e12629 Background: Triple-negative breast cancer (TNBC) prognosis is significantly influenced by tumor-infiltrating lymphocytes (TILs), but the lack of…”
Get full text

Dose dense versus 3 weekly AC during neoadjuvant chemoimmunotherapy for triple negative breast cancer by Bonadio, Renata Colombo, de Sousa, Isadora Martins, Balint, Flávia Cavalcanti, Comini, Ana Carolina Marin, Tavares, Monique Celeste, Madasi, Fernanda, Bines, Jose, Ferreira, Rafael Dal Ponte, Rosa, Daniela Dornelles, Santos, Candice Lima, de Souza, Zenaide Silva, Assad-Suzuki, Daniele, de Araújo, Júlio Antônio Pereira, Gagliato, Débora de Melo, dos Anjos, Carlos Henrique, Zucchetti, Bruna M., Ferrari, Anezka, de Brito, Mayana Lopes, Cangussu, Renata, Monteiro, Maria Marcela Fernandes, Hoff, Paulo M., Testa, Laura, Barroso-Sousa, Romualdo

“…Neoadjuvant pembrolizumab plus chemotherapy (P + CT) has emerged as a standard of care for stage II-III triple-negative breast cancer (TNBC). However, the best…”
Get full text

Emerging biomarkers in metastatic urothelial carcinoma: tumour mutational burden, PD-L1 expression and APOBEC polypeptide-like signature in a patient with complete response to anti-programmed cell death protein-1 inhibitor by Queiroz, Marcello Moro, de Souza, Zenaide Silva, Gongora, Aline Bobato Lara, de Galiza Barbosa, Felipe, Buchpiguel, Carlos Alberto, de Castro, Marilia Germanos, de Macedo, Mariana Petaccia, Coelho, Rafael Ferreira, Sokol, Ethan Samuel, Camargo, Anamaria Aranha, Bastos, Diogo Assed

“…Immunotherapy has recently been incorporated into the treatment guidelines for metastatic urothelial carcinoma. Nevertheless, the role of prognostic and…”
Get full text

Primary Peritoneal Carcinosarcoma in a Breast Cancer Patient Harboring a Germline BRCA2 Pathogenic Variant: Case Report by Mendes Gomes, Luciana Beatriz, Lazari Sandoval, Renata, Bragança Xavier, Camila, Strava Correa, Tatiana, Koga Matuda, Raquel Midori, Silva de Souza, Zenaide, Cernaglia Aureliano de Lima, Luiz Guilherme, Petaccia de Macedo, Mariana, Marino Carvalho, Filomena, Assad Suzuki, Daniele

“…Malignant mixed müllerian tumor (MMMT) is a rare neoplasm, consisting of carcinomatous (epithelial) and sarcomatous (mesenchymal) components that most commonly…”
Get full text